Forge Biologics

    Company Information

    Forge Biologics is based in Grove City, Ohio, USA. The number of employees in Forge Biologics is unknown. Forge biologics is a gene therapy development engine, focused on enabling access to life changing gene therapies.

    Here is how Forge Biologics describes itself: "Forge is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality. We are manufacturing hope."
      If you are the founder or part of the founding team, please tell the world your story


          Funding & investors

          Forge Biologics has received 1 rounds of venture funding. The total funding amount is around $40M.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors




                  Venture Competitors

                    News

                        Forge Biologics - Blog

                          • PRESS: Forge Biologics to Present at 2021 Virtual Cell and Gene Meeting on the Mediterranean

                          • COLUMBUS, OHIO April 6, 2021 – Forge Biologics, a cGMP manufacturing and development company, announced today that Timothy J. Miller, [...]Read More...The post PRESS: Forge Biologics to Present at 2021 Virtual Cell and Gene Meeting on the Mediterranean appeared first on Forge Biologics.
                          • Hearthside Chat Video Series

                          • We are excited to unveil our Hearthside Chat series – our version of a fireside chat – from our home [...]Read More...The post Hearthside Chat Video Series appeared first on Forge Biologics.
                          • PRESS: FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease

                          • The FDA has granted Fast Track Designation, Rare Pediatric Disease Designation, and Orphan Drug Designation to FBX-101 for treatment of patients [...]Read More...The post PRESS: FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease appeared first on Forge Biologics.
                          • PRESS: United Leukodystrophy Foundation

                          • We’re pleased to share that the United Leukodystrophy Foundation has shared our press release, marking yet another avenue of informing [...]Read More...The post PRESS: United Leukodystrophy Foundation appeared first on Forge Biologics.
                          • VIDEO: Manufacturing Capabilities

                          • We are passionate about serving our clients by providing the highest quality vector and leading the industry in technological advancements. [...]Read More...The post VIDEO: Manufacturing Capabilities appeared first on Forge Biologics.
                          • “Building Better” Blog: Forge Biologics Spotlight

                          • We are thrilled to have a spotlight in National Venture Capital Association‘s (NVCA) Building Better blog series alongside Molly (McCartin) Bonakdarpour of Drive [...]Read More...The post “Building Better” Blog: Forge Biologics Spotlight appeared first on Forge Biologics.

                          Share:     facebook    twitter    linkedin    reddit    email

                            Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                            Leave a Reply

                            Your email address will not be published. Required fields are marked *